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Background
Thymic Stromal Lymphopoietin (TSLP) is a potent immu-
nomodulatory cytokine involved in Th2-mediated immune
responses and homeostatic T-cell expansion. Reduced
TSLP expression by intestinal epithelial cells was recently
shown to lead to reduced Th2 responses and development
of Th1-mediated experimental colitis. Additionally, TSLP
is described as a proinflammatory factor in autoimmune
diseases. TSLP expression was studied in salivary glands of
primary Sjögren’s syndrome (pSS) patients as compared to
non-SS Sicca (nSS) patients and the relationship to local-
and systemic disease parameters was examined.
Methods
Tissue sections of minor salivary glands from 38 pSS and
18 nSS patients were stained with a monoclonal antibody
(mAb) against human TSLP or an isotype control. In addi-
tion, sections were stained with mAbs against CD3, CD19
and epithelial cell marker cytokeratin high molecular
weight (CK HMW) or stained with alcian blue to detect
mucus production. The number of TSLP-expressing cells
was quantified and expression was correlated to local- and
systemic disease parameters.
Results
TSLP was almost exclusively expressed by acinar cells
in both pSS and nSS patients. The number of TSLP-
expressing cells per mm2 was significantly decreased in
pSS patients as compared to nSS patients and correlated
negatively to Lymphocyte Focus Score (LFS), ESR, serum
IgG levels and positively to the percentage of local IgA pro-
ducing plasma cells. In pSS patients, TSLP was expressed
outside of lymphocytic infiltrates at sections that also
encompassed high numbers of intact, functional acinar
cells as analyzed with CK HMW and Alcian Blue staining.
Conclusions
TSLP expression is reduced in pSS patients, associated
with local- and systemic inflammatory markers.
Considering the described role of TSLP in promoting
Th2 responses at mucosal sites, we hypothesize that TSLP
is constitutively expressed in salivary glands and promotes
a protective Th2 milieu, whereas loss of TSLP expression
may contribute to Th1/Th17 associated immunopathology
in pSS.
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